The field of Antibody-Drug Conjugates (ADCs) has experienced a remarkable transformation, shifting from dormancy to a su...
Dr. Mohd Azizuddin bin Mohd Yussof, CT (IAC), Bsc. (Biomedical), MHealthSc. (Biomedical), PhD (Pathology) is the Directo...
The rapid spread of the original virus strain and its subsequent variants across the globe highlighted the importance of...
The Life Sciences market in China is expected to continue to develop, becoming one of the most diverse and expansive sec...
How would you describe the accomplishments at Eppendorf for FY 21-22, particularly in the APAC market? What drives your ...
At the start of this year, the new, more transmissible Omicron variant presented a fresh yet familiar set of challenges ...
Today’s pharma manufacturers are finding they need more robust tools to meet modern regulatory expectations around...
Pre-pandemic, the Asia Pacific region was already becoming a preferred destination for clinical trial studies.1 P...
New from OEM by QIAGEN: StableScript™, an off-the-shelf sensitive and efficient reverse transcriptase provided in ...
More than just working towards a paperless lab, digital transformation may allow companies to derive more intelligence f...
What are the new initiatives being planned for the APAC market? Are there any launches or announcements in the pipeline ...
There are more than 150 COVID-19 vaccines currently in development and an estimated 10 billion vaccine doses eventu...
Cytiva, formerly GE Healthcare Life Sciences, has recently announced an investment of $500 million for expansion of its ...
" The challenges with pandemic showed how resilient we are as an organization. The whole team in Japan, Austr...
The landscape is shifting rapidly for Asia’s biopharma and broader health sciences sector which has been thrust to...
Several Asian governments’ and officials have geared up to implement measures to control and mitigate the damages ...
Coronavirus pandemic has been a global threat to both healthcare and economy across the world. More than 200 countries a...
As biopharmaceutical production accelerates in Asia, global manufacturers are becoming increasingly exposed to supply ch...
